Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 211499
Company: ABHAI LLC

• REMS

Products on ANDA 211499

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
OXYCODONE AND ACETAMINOPHEN	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325MG/5ML;5MG/5ML	SOLUTION;ORAL	Prescription	AA	No	Yes

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 211499

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/31/2018	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/22/2025	SUPPL-14	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.
10/31/2024	SUPPL-10	REMS - MODIFIED - D-N-A		Label is not available on this site.
03/27/2024	SUPPL-9	Labeling-Package Insert		Label is not available on this site.
12/15/2023	SUPPL-7	Labeling-Package Insert		Label is not available on this site.
03/05/2021	SUPPL-3	Labeling-Package Insert, Labeling-Package Insert		Label is not available on this site.
10/07/2019	SUPPL-1	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 211499

OXYCODONE AND ACETAMINOPHEN

SOLUTION;ORAL; 325MG/5ML;5MG/5ML
TE Code = AA

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
OXYCODONE AND ACETAMINOPHEN	ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE	325MG/5ML;5MG/5ML	SOLUTION;ORAL	Prescription	No	AA	211499	ABHAI LLC